Yawei Huang

477 total citations
19 papers, 369 citations indexed

About

Yawei Huang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yawei Huang has authored 19 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yawei Huang's work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Autophagy in Disease and Therapy (4 papers). Yawei Huang is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Autophagy in Disease and Therapy (4 papers). Yawei Huang collaborates with scholars based in China. Yawei Huang's co-authors include Zhenfeng Ye, Xiaoqing Xi, Meng Wu, Shiguang Yang, Weichao Wang, Honglin Hu, Cong Zou, Xinxue Zhang, Jiatao Liu and Hanqing Yu and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Frontiers in Immunology.

In The Last Decade

Yawei Huang

17 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yawei Huang China 7 241 188 62 39 39 19 369
Chuanfu Li United States 5 197 0.8× 108 0.6× 56 0.9× 28 0.7× 34 0.9× 7 403
Ranchen Xu China 6 351 1.5× 179 1.0× 41 0.7× 56 1.4× 39 1.0× 7 463
Cunzao Wu China 11 253 1.0× 115 0.6× 96 1.5× 61 1.6× 38 1.0× 19 474
Jingxiao Lu China 12 170 0.7× 72 0.4× 78 1.3× 56 1.4× 45 1.2× 20 353
Yueling Jin China 11 218 0.9× 108 0.6× 36 0.6× 29 0.7× 19 0.5× 21 353
Jiao Wan China 10 309 1.3× 223 1.2× 41 0.7× 30 0.8× 20 0.5× 11 439
Tiantian Cheng China 9 408 1.7× 353 1.9× 64 1.0× 49 1.3× 34 0.9× 24 598
Yue Ge China 5 241 1.0× 189 1.0× 52 0.8× 27 0.7× 16 0.4× 9 350

Countries citing papers authored by Yawei Huang

Since Specialization
Citations

This map shows the geographic impact of Yawei Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yawei Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yawei Huang more than expected).

Fields of papers citing papers by Yawei Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yawei Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yawei Huang. The network helps show where Yawei Huang may publish in the future.

Co-authorship network of co-authors of Yawei Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Yawei Huang. A scholar is included among the top collaborators of Yawei Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yawei Huang. Yawei Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Huang, Yawei, et al.. (2025). Constructing a machine learning model for systemic infection after kidney stone surgery based on CT values. Scientific Reports. 15(1). 4327–4327. 5 indexed citations
3.
Lai, Sha, et al.. (2024). Promoting equality in utilization of basic public health services in China: the role of the family doctor contract service. Journal of Medical Economics. 27(1). 1444–1455. 1 indexed citations
4.
Li, Jiaxin, et al.. (2024). Predictive value of machine learning model based on CT values for urinary tract infection stones. iScience. 27(12). 110843–110843. 1 indexed citations
6.
Zhu, Fei, et al.. (2023). Identification of differentially expressed circRNAs in prostate cancer of different clinical stages by RNA sequencing. Scientific Reports. 13(1). 21175–21175. 1 indexed citations
7.
Zhang, Chiyu, et al.. (2023). Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltration. Frontiers in Immunology. 14. 1197011–1197011. 3 indexed citations
8.
Chen, Ziliang, et al.. (2023). Study on the intervention effect of Epimedium before and after suet-oil-processed on kidney yang deficiency rats based on intestinal flora and fecal metabolomics. Journal of Pharmaceutical and Biomedical Analysis. 240. 115957–115957. 2 indexed citations
9.
Huang, Yawei, Chiyu Zhang, Zhenfeng Ye, et al.. (2022). Identification of cuproptosis-related long noncoding RNA signature for predicting prognosis and immunotherapy response in bladder cancer. Scientific Reports. 12(1). 21386–21386. 6 indexed citations
10.
Qiu, Yao, et al.. (2022). Gender Differential Expression of AR/miR-21 Signaling Axis and Its Protective Effect on Renal Ischemia-Reperfusion Injury. Frontiers in Cell and Developmental Biology. 10. 861327–861327. 3 indexed citations
11.
Xi, Xiaoqing, et al.. (2019). Pioglitazone protects tubular cells against hypoxia/reoxygenation injury through enhancing autophagy via AMPK-mTOR signaling pathway. European Journal of Pharmacology. 863. 172695–172695. 40 indexed citations
12.
Qiu, Yao, Weichao Wang, Zhenfeng Ye, et al.. (2019). Involvement of androgen receptor (AR)/microRNA-21 axis in hypoxia/reoxygenation-induced apoptosis of mouse renal tubular epithelial cells.. PubMed. 11(9). 5611–5622. 3 indexed citations
13.
Chen, Wenlin, Xiaoqing Xi, Shuangyang Zhang, et al.. (2018). Pioglitazone Protects Against Renal Ischemia-Reperfusion Injury via the AMP-Activated Protein Kinase-Regulated Autophagy Pathway. Frontiers in Pharmacology. 9. 851–851. 38 indexed citations
14.
Wang, Pengfei, et al.. (2018). The protective and therapeutic effects of total flavonoids of Astragalus against bleomycin-induced pulmonary fibrosis are through the enhancement of autophagy. Journal of Traditional Chinese Medical Sciences. 5(4). 380–389. 6 indexed citations
15.
Wu, Meng, Yawei Huang, Weichao Wang, et al.. (2018). LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR‐9‐5p/QKI‐5 axis. Journal of Cellular and Molecular Medicine. 23(1). 29–38. 119 indexed citations
16.
Zhang, Xinxue, et al.. (2017). Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice. Drug Design Development and Therapy. Volume11. 1065–1079. 56 indexed citations
17.
Wang, Fang, Jiatao Liu, Yanfeng Zou, et al.. (2017). MicroRNA-143-3p, up-regulated in H. pylori-positive gastric cancer, suppresses tumor growth, migration and invasion by directly targeting AKT2. Oncotarget. 8(17). 28711–28724. 52 indexed citations
18.
Huang, Yawei, Guoping Sun, Jiatao Liu, et al.. (2016). miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1. OncoTargets and Therapy. 9. 1623–1623. 29 indexed citations
19.
Wang, Longwang, et al.. (2014). SKIP expression is correlated with clinical prognosis in patients with bladder cancer.. PubMed. 7(4). 1695–701. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026